Senate budget
This article was originally published in The Gray Sheet
Executive Summary
Appropriations Committee approves $1.1 bil. increase to NIH budget at Sept. 15 mark-up, bringing agency to $28.91 bil. for FY 2005. The Senate version represents an increase over a Sept. 9 House budget earmarking $28.51 bil. for NIH. The Senate bill echoes House recommendations that CMS develop a wheelchair coverage policy "firmly based on a functional standard" of what it means for a patient to be "non-ambulatory," including "beneficiaries who cannot perform their basic acts of daily living, toileting, food preparation and emergency egress." The Senate and House both note the cost-effectiveness of avoiding institutional care or hospitalization. At a Sept. 1 town meeting, CMS had proposed new payment codes to help combat power wheelchair fraud (1"The Gray Sheet" Sept. 6, 2004, p. 15)...
You may also be interested in...
Medicare Revisits Power-Wheelchair Codes; ECRI Wants More iBOT Studies
ECRI recommends larger, longer-term studies of Johnson & Johnson/Independence Technology's iBOT 3000 stair-climbing power wheelchair to better determine the device's cost-to-benefit ratio
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.